MIMETAS is attending the 2026 World Molecular Imaging Congress in Salt Lake City.

Public source

Publisher name

Public post

We’re at the 2026 World Molecular Imaging Congress in Salt Lake City this week! MIMETAS is taking part in several sessions throughout the conference, discussing the role…

Log in to read the full post

Company

MIMETAS

Human Tissue Models for Better Therapies

Industry
Biotechnology Research
Location
Oegstgeest, NL
Company size
51–200 employees

About MIMETAS

We strive to contribute to groundbreaking therapies with our screenable, physiologically relevant 3D human disease models. By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases. For more information, visit: www.mimetas.com.

See more

Latest activity

7 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.